相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pharmacological Properties of Chalcones: A Review of Preclinical Including Molecular Mechanisms and Clinical Evidence
Bahare Salehi et al.
FRONTIERS IN PHARMACOLOGY (2021)
The Role of DPP-4 Inhibitors in the Treatment Algorithm of Type 2 Diabetes Mellitus: When to Select, What to Expect
Konstantinos Makrilakis
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2019)
Acarbose Add-on Therapy in Patients with Type 2 Diabetes Mellitus with Metformin and Sitagliptin Failure: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
Hae Kyung Yang et al.
DIABETES & METABOLISM JOURNAL (2019)
4-Hydroxyderricin Isolated from the Sap of Angelica keiskei Koidzumi: Evaluation of Its Inhibitory Activity towards Dipeptidyl Peptidase-IV
Diah Lia Aulifa et al.
SCIENTIA PHARMACEUTICA (2019)
Bioactive flavonoids in medicinal plants: Structure, activity and biological fate
Tian-yang Wang et al.
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Assessment of Enzyme Inhibition: A Review with Examples from the Development of Monoamine Oxidase and Cholinesterase Inhibitory Drugs
Rona R. Ramsay et al.
MOLECULES (2017)
Chalcone: A Privileged Structure in Medicinal Chemistry
Chunlin Zhuang et al.
CHEMICAL REVIEWS (2017)
Comparative Binding Analysis of Dipeptidyl Peptidase IV (DPP-4) with Antidiabetic Drugs - An Ab Initio Fragment Molecular Orbital Study
Sundaram Arulmozhiraja et al.
PLOS ONE (2016)
Effect of Acarbose, Sitagliptin and combination therapy on blood glucose, insulin, and incretin hormone concentrations in experimentally induced postprandial hyperglycemia of healthy cats
Akihiro Mori et al.
RESEARCH IN VETERINARY SCIENCE (2016)
Metabolic role of dipeptidyl peptidase 4 (DPP4) in primary human (pre)adipocytes
Pia Zillssen et al.
SCIENTIFIC REPORTS (2016)
Chalcones and their therapeutic targets for the management of diabetes: Structural and pharmacological perspectives
Debarshi Kar Mahapatra et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
β-cell dysfunction: Its critical role in prevention and management of type 2 diabetes
Yoshifumi Saisho
WORLD JOURNAL OF DIABETES (2015)
The Effects of Dipeptidyl Peptidase-4 Inhibition on Microvascular Diabetes Complications
Angelo Avogaro et al.
DIABETES CARE (2014)
A comparative study of the binding modes of recently launched dipeptidyl peptidase IV inhibitors in the active site
Mika Nabeno et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Xanthoangelol and 4-Hydroxyderricin Are the Major Active Principles of the Inhibitory Activities against Monoamine Oxidases on Angelica keiskei K
Ji Ho Kim et al.
BIOMOLECULES & THERAPEUTICS (2013)
Molecular Basis for the Recognition of Long-chain Substrates by Plant α-Glucosidases
Takayoshi Tagami et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Angelica keiskei Extract Improves Insulin Resistance and Hypertriglyceridemia in Rats Fed a High-Fructose Drink
Hiromu Ohnogi et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2012)
Bioassay-guided screening and isolation of α-glucosidase and tyrosinase inhibitors from leaves of Morus alba
Zhenzhong Yang et al.
FOOD CHEMISTRY (2012)
Compounds from Angelica keiskei with NQO1 induction, DPPH• scavenging and α-glucosidase inhibitory activities
Liping Luo et al.
FOOD CHEMISTRY (2012)
Critical evaluation of the role of acarbose in the treatment of diabetes: patient considerations
Christoph Rosak et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2012)
Rapid Tachyphylaxis of the Glucagon-Like Peptide 1-Induced Deceleration of Gastric Emptying in Humans
Michael A. Nauck et al.
DIABETES (2011)
Pharmacological management of type 2 diabetes: the potential of incretin-based therapies
B. Charbonnel et al.
DIABETES OBESITY & METABOLISM (2011)
Dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes: a comparative review
C. F. Deacon
DIABETES OBESITY & METABOLISM (2011)
Prenylated chalcones 4-hydroxyderricin and xanthoangelol stimulate glucose uptake in skeletal muscle cells by inducing GLUT4 translocation
Kyuichi Kawabata et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2011)
Emerging role of dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes
Bernd Richter et al.
VASCULAR HEALTH AND RISK MANAGEMENT (2008)
Antidiabetic activities of chalcones isolated from a Japanese herb, Angelica keiskei
Tatsuji Enoki et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2007)
(2R)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-α]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine:: A potent, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes
D Kim et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
分享论文
